Identification of Active Components in Connarus ruber Extract Exhibiting Anti-Glycation Effects
These findings suggest that epicatechin and procyanidin A2 are candidate contributors to the anti-glycation and cytoprotective effects of <i>C. ruber</i>. The results support the potential of <i>C. ruber</i> extract as a source of therapeutic agents for glycation-related diseases and for enhancing stem cell viability.
Authors
- Mariko Takenokuchi (ORCID: https://orcid.org/0000-0002-2776-9632)
- Yuka Sasaki (ORCID: https://orcid.org/0000-0001-5841-1898)
- Ryusuke Nakatsuka
- Hirohito Kubo
- Tomio Iseki
- Takashi Maoka
- Rika Taniguchi (ORCID: https://orcid.org/0000-0001-8263-4012)
- Tadashige Nozaki
Institutions
- Daiichi University of Pharmacy (JP)
- Research Institute for Production Development (JP)
- Osaka Dental University (JP)
Publication Details
- Journal
- Medicines
- Published
- 2025-12-03
- DOI
- https://doi.org/10.3390/medicines12040029
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 0.00